Latest Investment News

Piche Resources has received formal environmental approval to begin its maiden drilling campaign at the Cerro Chacon gold-silver project in Argentina, targeting a 14 km mineralised corridor with 57 planned drill holes.

American West Metals has successfully raised A$5.9 million as part of a broader A$14.4 million funding package to advance its Storm Copper Project in Canada, aiming to fast-track exploration and development activities.

Ionic Rare Earths, through its Viridion joint venture, has delivered the first recycled rare earth oxides to Brazil’s CIT SENAI ITR, marking a key step toward a domestic magnet supply chain in South America.

Aurum Resources has secured a joint venture to earn up to 80% interest in two new exploration permits adjacent to its 1.6Moz Boundiali Gold Project in Côte d'Ivoire, significantly expanding its landholding and growth potential.

Kingsrose Mining advances its exploration efforts in Norway’s Finnmark region with increased backing from BHP, while winding down its Central Finland alliance. The company also secures an option to acquire the promising Gallujavri nickel-copper-PGE project.

Atturra Limited is set to acquire DalRae Solutions, a specialist SAP consultancy, in a deal valued up to $20 million that aims to deepen its SAP capabilities and market reach.

Antilles Gold’s joint venture has inked key offtake agreements for all gold and copper/gold concentrates from the Nueva Sabana mine, boosting project financing prospects.

Strickland Metals reports robust diamond drilling results at its Gradina Prospect, extending high-grade gold mineralisation and setting the stage for a maiden resource estimate in late 2025.

Straker Ltd reports a solid FY25 performance marked by a strategic shift from legacy translation services to AI-powered language verification, underpinned by robust cash reserves and improved profitability.

ALS Limited has announced a fully underwritten A$350 million equity placement to fund major upgrades to its global laboratory network and support future growth initiatives, aiming for mid single-digit EPS accretion by FY25 pro forma.

ALS Limited delivered a robust FY25 performance with 16% revenue growth to $3 billion and underlying EBIT rising 4.7% to $515 million, driven by strong organic growth and strategic acquisitions. The company is advancing its Nuvisan integration ahead of schedule and has unveiled a $230 million investment plan to expand key laboratories, positioning itself for sustained growth amid market uncertainties.

ALS Limited reported a robust FY25 with $3 billion revenue driven by Life Sciences growth and resilient Commodities, announcing a $350 million equity raise to fund strategic expansion.